LifeWey
Life Sciences
Entity

Semaglutide

Drug · Tracked through publications, trial updates, and regulatory events.

DRUGPublicIndexable
Novo Nordisk · COMPANYObesity · DISEASENCT12345678 · CLINICAL_TRIALFDA · REGULATOR
Reading surface

Overview

ENTITY

Semaglutide

Drug · Tracked through publications, trial updates, and regulatory events.

DRUGPublicIndexable
TIMELINE
DRUG_APPROVALlifewey:drug-approval
DRUG_APPROVALacq:d171b22cf8c77a9f
CLINICAL_TRIAL_PHASE_CHANGEacq:9262125a96bb548a
RESEARCH_PUBLICATIONlifewey:semaglutide-study-publication
RELATED ENTITIES
Novo Nordisk · COMPANYObesity · DISEASENCT12345678 · CLINICAL_TRIALFDA · REGULATOR
SOURCES
FDAFDA Press Announcements
Family: FDA · Authority: PRIMARY_REGULATORY · https://www.fda.gov/
PubMedPubMed Life Sciences Feed
Family: PUBMED · Authority: PRIMARY_SCIENTIFIC · https://pubmed.ncbi.nlm.nih.gov/
ClinicalTrials.govClinicalTrials.gov Study Updates
Family: CLINICALTRIALS · Authority: PRIMARY_SCIENTIFIC · https://clinicaltrials.gov/
TYPE-SPECIFIC FACTS
Trial contextClinicalTrials.gov updates semaglutide obesity trial phase · ClinicalTrials.gov updates semaglutide obesity trial phase
Regulatory contextFDA approves semaglutide label expansion · FDA approves semaglutide label expansion
Related conditionObesity